Prismatic Law Group Partners Ron and Debora attended the AIPLA Spring Meeting in Minneapolis from May 18-20. Debora spoke about issues surrounding Genetic Resources at the Biotech/FDA Committee CLE Panel entitled: “Mars 101-International and Interplanetary Considerations for GMOs: Patents, Export control, Biodiversity and Regulation.”
Uncategorized
May 2016 Prismatic Law Newsletter
WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC)
Overview of Convention on Biological Diversity, Nagoya Protocol and WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore
By: Debora Plehn-Dujowich, Ph.D., J.D.[1]
Background
The 29th session of the Intergovernmental Committee on […]
February 2016
Ron Kamis and Debora Plehn-Dujowich are happy to announce the formation of Prismatic Law Group, PLLC. We assist companies with intellectual property legal counseling with a focus on biotechnology, pharmaceuticals and industrial chemicals.
Recent Activities
Ron Kamis Prismatic […]
Trade Secrets Versus Patents – Does the New Law on Patent Subject Matter Eligibility Change Anything?
Author: Ron J. Kamis
I attended the January 8, 2015 Trade Secret Symposium held at the United States Patent and Trademark Office (“USPTO”). Among other topics, the Symposium covered the strategic choice between patenting and keeping technology as a trade secret. The panel for this topic […]
Lean Times Ahead at the U.S. Patent Office for Biotech and Chemical Patents
Author: Ron J. Kamis
This post discussing the Patent Office’s examination policy regarding biotechnology and chemical inventions following the recent Supreme Court Myriad decision.
As many of you already know, on March 4, 2014, the United States Patent and Trademark Office (PTO) issued guidelines to […]